Advertisement
Advertisement
APUS
Apimeds Pharmaceuticals US, Inc.
4.24
USDSponsored
+0.01
+0.24%
Aug 10, 16:00 UTC -4
Closed
After-Market
4.26
+0.02
+0.59%
Apimeds Pharmaceuticals US, Inc. Financial Snapshot
| Market Cap | 6.44M |
| Beta | 0.16 |
| Earnings Per Share (EPS) | -27.40 |
| Price-to-Book (P/B) Ratio | 0.04 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 7.40% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -54.65% |
| Current Ratio | 0.90% |
| Free Cash Flow | -2.08M |
Trending Stocks
Advertisement